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Background: The Childhood Atopic Dermatitis Impact Scale (CADIS) was developed to measure the
impact of AD on QoL in both affected children and their families. However, no scale of this kind exists in
Japan. The aims of this study were to validate the Japanese Culturally Modiﬁed Version of the CADIS
(JCMV-CADIS) and to describe the family impact of children with AD in a Japanese context.
Methods: Participants included primary-caregivers for children with AD between 2 and 6 years of age.
Interviews were conducted, and new items for the Japanese version were drafted. Reliability and validity
were evaluated and compared with the original CADIS, and unique features of the Japanese version were
analyzed.
Results: Exploratory factor analysis revealed the following factors: “Symptoms” and “Activity Limitations
and Behavior” in the Child domain, and “Emotions Related to Social Factors,” “Emotions Related to the
Child's Condition,” “Family and Social Function,” “Complexity of Care,” and “Approaches to Management
of AD in Daily Life” in the Parent domain. The latter two factors were unique to the JCMV-CADIS and were
not derived from the Original. “Emotion” was split into two independent factors. All factors showed good
reliability (internal consistency and stability) and validity (concurrent validity and discriminant validity),
except for the concurrent validity of “Approaches to Management of AD in Daily Life.” This factor seemed
to reﬂect characteristics similar to the family-related function.
Conclusions: The JCMV-CADIS is a QoL scale developed for Japanese children with AD and their families.
Further evaluation of clinical applicability is needed.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Atopic dermatitis (AD) is a chronic, pruritic inﬂammatory skin
disease that occurs most frequently in children (17% of American
children), but that also affects many adults.1,2 In Japan, 12.8% of 4-
month-old children, 9.8% of 18-month-old children, and 13.2% of
3-year-old children are affected by AD3 and the incidence appears
to be increasing.Health Nursing, Nagoya City
ho, Mizuho-ku, Nagoya, Aichi
. Yamaguchi).
ety of Allergology.
rgology. Production and hosting by ElseAD inﬂuences physical health as well as emotional and social
well-being,4e7 and is documented to inﬂuence the daily lives of
parents and caregivers. Faught et al. found that the impact on the
daily lives of caregivers of childrenwith eczema, especially in terms
of parenting stress, was comparable to that on the daily lives of
individuals raising children with other chronic maladies, such as
diabetes or deafness.8 Chamlin et al. reported that AD inﬂuences the
sleep patterns of both affected children and their parents.9 A study
by Moore et al. revealed that parents of children with AD reported
signiﬁcantly more sleep disorders than parents of children with
asthma.10 They also found that the severity of parents' sleep
disruption correlates with anxiety and depression in mothers and
with anxiety in fathers.
Although a number of quantitativemeasures of the impact of AD
on the QOL of children and their parents have been developed,vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
C. Yamaguchi et al. / Allergology International 65 (2016) 312e319 313comprehensive measures of the impact of AD on the family as a
whole are limited to the Dermatitis Family Impact (DFI)11 and the
Childhood Atopic Dermatitis Impact Scale (CADIS).7,12 Compared to
the DFI, the CADIS includes a greater number of items, likely
reﬂecting a more comprehensive measurement of QoL. Although
the concurrent validity of the CADIS and other existing measures of
QOL has not been veriﬁed and this tool has yet to be used in clinical
research,13,14 its value lies in the ability to comprehensively mea-
sure the QoL effects of both children with AD and their parents. Of
note, Neri et al. developed the Italian version of the CADIS.15
The aims of this study were to validate the Japanese Culturally
Modiﬁed Version of the CADIS (JCMV-CADIS) and to describe the
family impact of AD in the Japanese context by comparing the
JCMV-CADIS to the original version.
Methods
Study design
This study beganwith the creation of a direct Japanese-language
translation of the original CADIS. First, three Japanese individuals
with numerous years of experience living in the United States
translated the original CADIS into Japanese. Next, it was back-
translated into English and the equivalence of the back-
translation and the original CADIS was veriﬁed by an American
linguist. Next, a native Japanese-speaking linguist checked the
validity of the Japanese-language version.
To verify face validity, the Japanese-language version was
checked by ﬁve Japanese family members of children with AD, and
the wording of some items was changed based on their feedback.
Qualitative, open-ended interviews were then conducted with
the same ﬁve Japanese primary caregivers of children with AD, and
new items for the Japanese version were created. Items in the
modiﬁed scale were compared to those of the original version, and
the unique features of the Japanese version were examined.
Participants
Participants were the caregivers of children aged between 2 and
6 years old who had been diagnosed with AD were recruited at 30
Japanese hospitals or clinics. In this study, the reasons that the age
of participants of children with AD was set to 2e6 years old are as
follows; We set the age over 2 years old because children eat baby
food until around 2 years old. In the Family Impact of AD, we
assumed that diet would be a difﬁculty, but that baby food prepa-
rations would be equally difﬁcult for children with or without AD.
Also, difﬁculties of child care that did not relate to the presence of
the diseasewere predicted in the stages of development from 0 to 1
year old, when the primary caregiver must see to all aspect of child
care regardless of the presence of AD. Thus, in this study, we limited
the age of participants of children with AD to 2 years old or older.
The reasonwe limited the study to pre-school children is because it
is thought that characteristics of development are different from
schoolchildren.
Disease severity was measured by a pediatric allergist using the
Severity Scoring of Atopic Dermatitis (SCORAD) Index. Only native
Japanese speakers with the ability to complete a written survey
were selected.
Ethical considerations
The interview participants received either verbal or written
explanation before the research and provided written informed
consent. The questionnaire respondents received writtenexplanation, and if they sent the completed questionnaire, consent
was considered obtained.
The explanation was as follows: Participation in this study is
based on the free will of the person. There are no disadvantages to
not participating in the study. Participant's personal identifying
information will be made indistinguishable. The data will be kept
secure, and will not be used for purposes other than for this study.
This study was approved by the ethics committee at Nagoya
University Graduate School of Medicine (Approval Nos. 9-165 and
11-135).
Instruments
The following scales were administered to all participants:
Childhood Atopic Dermatitis Impact Scale (CADIS);
Severity Scoring of Atopic Dermatitis (SCORAD) for evaluation
of the severity of AD;
Dermatitis Family Impact (DFI) for evaluation of impact on the
family;
Parenting Stress-Short Form (PS-SF) for evaluation of parenting
stress; and
Family Assessment Inventory (FAI) for evaluation of family
functionChildhood Atopic Dermatitis Impact Scale (CADIS)7,12
Chamlin et al. developed a measure of the impact of AD on the
QOL of both affected children and their families. Altogether, ﬁve
subdomains are included: the Child domain consists of “Symp-
toms” and “Activity Limitations and Behavior,” while the Parent
domain consists of “Family and Social Function,” “Sleep,” and
“Emotions.” The total score ranges from 0 to 180, with 0 for “Never”
to 4 for “All the Time” for each of the 45 items. The lower the total
score, the lower the impact of AD
Severity Scoring of Atopic Dermatitis (SCORAD)16,17
SCORAD is a set of international criteria to assess the severity of
eczema. The Japanese Dermatology Association cites the Japanese-
language version of SCORAD in its AD guidelines.18
Dermatitis Family Impact (DFI)11
This instrument measures the impact of a condition on the QOL
of the family, just as the CADIS does. The DFI is a disease-speciﬁc
instrument with veriﬁed validity and reliability. A lower score in-
dicates lower impact. Ohya et al. developed a Japanese-language
version of the instrument.19
Parenting Stress-Short Form (PS-SF)20,21
The Parenting Stress Index (PSI) is an instrument that measures
many facets of childcare stress, such as social factors affecting
parents, parents' personalities, and character traits of children. This
instrument is divided into subscales for parents and children.
Narama et al. developed a Japanese-language version of this in-
strument.20 This study used an abbreviated Japanese-language
version, the PS-SF.21 A lower score indicates lower parenting stress.
Family Assessment Inventory (FAI)22
The FAI was developed with the goal of understanding the
functional status of family systems, and consists of subscales of
“Family Communication,” “Family System Flexibility,” “Family
Rules,” “Family Evaluation,” and “Family Cohesion.” A lower score
indicates lower family functionality.
Table 1
Characteristics of children and caregivers (N ¼ 233).
Children N (%)y
Mean ±SD
Mean age 3.79 ±1.38
Age
2 53 22.7
3 55 23.6
4 48 20.6
5 41 17.6
6 36 15.5
Sex
Male 137 58.8
Female 96 41.2
Children in family
1 73 31.3
2 124 53.2
3 33 14.2
4 1 .4
5 2 .9
Birth order
1 144 61.8
2 74 31.8
3 12 5.2
4 1 .4
5 2 .9
Severity
Total SCORAD 20.27 ±16.53
Mild (<25) 135 57.9
Moderate 65 27.9
Severe (>50) 12 5.2
Allergy-related complications
Yes 168 72.1
No 64 27.5
Asthma 65 38.7
Food allergy 132 78.6
Allergic rhinitis 24 14.3
Allergic conjunctivitis 2 1.2
Other 1 .6
Caregivers N (%)y
Mean ±SD
Mean age of father 38.44 ±5.19
Occupation of father
Full-time job 207 88.8
Part-time job 1 .4
Self-employed 18 7.7
Temporarily unemployed 1 .4
Mean age of mother 36.16 ±4.04
Occupation of mother
Full-time job 45 19.3
Part-time job 39 16.7
Self-employed 14 6.0
Working at home 2 .9
Unemployed 117 50.2
Temporarily unemployed 14 6.0
Primary caregiver during the day
Mother 113 48.5
Nursery school 117 50.2
Other 3 1.3
Marital status
Single 5 2.1
Married/Living with partner 221 94.8
Separated 7 3.0
Family history of atopic dermatitis
Yes 200 85.8
No 32 13.7
Satisfaction with treatment
Satisﬁed 203 87.1
Not satisﬁed 20 8.6
y Percentages do not always add up to 100 because of missing values.
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Factor analyses were performed using principal axis factoring
with a Promax rotation. The missing values were replaced with a
mean. Based on the factor structure of the original CADIS, separate
factor analyses of items related to children and items related to
parents were performed. The number of factors was decided based
on use of factors with a cumulative contribution ratio of at least
50%.23 If one factor consisted of only a single item, the number of
factors would be decreased and factor analysis would then be
performed again. The minimum loading for an item to be retained
was set at 0.32.24
Concurrent validity tests were performed by testing the corre-
lation of each factor in the JCMV-CADIS with the DFI and SCORAD.
Correlation was veriﬁed with Spearman's correlation coefﬁcient.
Discriminant validity tests were performed with the PS-SF,
which has a structure that divides factors into child and parent
dimensions like the CADIS, and the FAI, which measures family
function.
Reliability
Cronbach's alphawas calculated for each factor in order to verify
internal consistency. Test-retest reliability was performed to verify
stability. Participants (10% of the target group) were requested to
complete the retest 48 h after the initial survey.
Results
Demographic characteristics
Surveys were sent to 621 families of children with AD. Of these,
270 were returned, and data from 233 were analyzed in this study
(37.5% of distributed surveys, 86.3% of returned surveys). Children
not meeting age criteria were excluded from analysis, and surveys
with >10% missing values of CADIS were excluded. Details of
participant demographics are shown in Table 1.
Creation of the Japanese Culturally Modiﬁed Version of the CADIS
(JCMV-CADIS)
First, we created a Japanese-language version of the CADIS.
Next, we conducted interviews with primary caregivers of Jap-
anese children with AD and 8 new items were added to the scale,
for reasons described in the text.
 This skin condition has made me more careful about my child's
diet.
 This skin condition has made me more careful about my child's
environment.
 I feel that I have adapted to the everyday life of caring for a child
with atopic dermatitis.
 I feel that our whole family is helping with the care of my child's
atopic dermatitis.
 I can deal with the prospect of long-term care for my child.
 I can accept that I cannot manage the situation perfectly.
 Child himself/herself takes the behavior avoiding symptom
aggravation of the AD.
 This skin conditions worsens relationships with siblings.
After this, we conducted a quantitative study with a question-
naire which contains the 45 original items and the 8 new items
from the interviews.
As a result of this, the item “This skin condition worsens re-
lationships with siblings” was excluded from this study because 15
C. Yamaguchi et al. / Allergology International 65 (2016) 312e319 315participants did not answer this item. Analysis was thus based on
seven new items (one item added to a Child domain, six items
added to the Parent domain).Factor structure of the Japanese Culturally Modiﬁed Version of the
CADIS (JCMV-CADIS)
Exploratory factor analysis (EFA) was performed by analyzing
the 16 items in the Child domain, plus one added based on in-
terviews with Japanese parents, and the 29 items in the Parent
domain, plus six new items, separately, as performed in the original
version of the CADIS. Of note, EFA results produced a different
factor structure than the original CADIS.
Analyses of the JCMV-CADIS revealed a KMO of .894 (P < 0.01)
and it indicated that the data set characteristics were adequate for
performing factor analysis.
Final version of JCMV-CADIS is shown in Supplementary data.Child domain
Factor analysis of the Child domain identiﬁed three factors with
a cumulative contribution ratio of 52.4%. One of these factors
included only a single item, so the number of factors was reduced to
two and the analysis was repeated. The ﬁrst factor included nine
items, including six from the “Symptoms” of the original version,
but three items were inconsistent with the original. After
comprehensive consideration of these items, the decision was
made to retain the designation “Symptoms” for this factor. The
second factor included three items, including two from the “Ac-
tivity Limitations and Behavior” of the original version, but one
item was inconsistent. After comprehensive consideration of the
items, the decision was made to retain the designation “Activity
Limitations and Behavior” for this factor.
Items with a low commonality and a low factor loading (ﬁve
items) were discarded. As a result, 12 items were included in the
Child domain. Details are shown in Table 2.Parent domain
Factor analysis of the Parent domain identiﬁed ﬁve factors with
a cumulative contribution ratio of 52.1%.Table 2
Exploratory factor analysis of the JCMV-CADIS (child domain).
Items Fact
9. My child scratches or rubs his/her skin. Sym
1. This skin condition affects how well my child sleeps. Sym
10. This skin condition makes my child feel frustrated. Sym
6. This skin condition makes my child fussy or irritable. Sym
14. My child's skin seems to be painful or irritated. Sym
12. My child seems to cry more because of this skin condition. Sym
22. My child's itching or scratching affects his/her play. Acti
21. Taking a bath makes my child uncomfortable. Acti
27. Certain fabrics or clothes seem to bother my child's skin. Acti
29. It is difﬁcult to discipline my child because of this skin condition. Acti
34. My child misbehaves more because of this skin condition. Acti
17. My child seems to be restless or hyperactive because of this skin condition. Sym
Principal axis factoring.
Promax with Kaiser Normalization.
Rotation converged in 3 iterations.The ﬁrst factor included six items, all from the original version's
“Emotion” domain. After consideration, the designation “Emotions
Related to Social Factors”was given to this factor. The second factor
included eight items, including six from the “Emotion” of the
original version; the other two were from the “Sleep.” After
comprehensive consideration of the items, the factor was desig-
nated “Emotions Related to the Child's Condition.”
The third factor included ﬁve items, all from the “Family and
Social Function” of the original version. The same designation was
therefore retained.
The fourth factor included six items, three from the original
version's “Emotion” and three from its “Family and Social Func-
tion.” After consideration of the items included, the factor was
designated “Complexity of Care.”
The ﬁfth factor consisted of six items, all new items based on the
interviews with Japanese caregivers. These items concern issues
such as using measures to prevent symptoms worsening, working
together with the whole family for long-term management, and
accepting that the provided care is not “perfect treatment,” but
rather “good enough treatment.” For these reasons, the designation
“Approaches to Management of AD in Daily Life” was given to this
factor.
Items with low commonality and low factor loading (four items)
were discarded. The Parent domain thus included 25 items from
the original version and six additional items, for a total of 31 items.
Details are shown in Table 3.Reliability
Internal reliability
Cronbach's alpha for internal reliability in the Child domain was
.729e.884. In the Parent domain, Cronbach's alpha was .734e.839.
The high alpha values for all factors indicate good internal
reliability.Test-retest reliability
Nineteen participants completed the surveys twice at a 48 h
interval. Spearman's rho was .925 for “Symptoms,” .899 for “Ac-
tivity Limitations and Behavior,” .867 for “Emotions Related to So-
cial Factors,” .847 for “Emotions Related to the Child's Condition,”
.922 for “Family and Social Function,” .917 for “Complexity of Care,”ors in original version Factors and loading Cronbach's a
Symptoms Activity Limitations
and Behavior
ptoms .854 .192 .884
ptoms .814 .147
ptoms .755 .093
ptoms .753 .086
ptoms .692 .031
ptoms .659 .094
vity Limitations and Behavior .439 .343
vity Limitations and Behavior .376 .222
vity Limitations and Behavior .350 .233
vity Limitations and Behavior .123 .855 .729
vity Limitations and Behavior .069 .742
ptoms .172 .527
Table 3
Exploratory factor analysis of the JCMV-CADIS (Parent domain).
Items Factors in the
original version
Factors and loading Cronbach's a
Emotions Related
to Social Factors
Emotions Related
to the Child's
Condition
Family and
Social Function
Complexity
of Care
Approaches
to Management
of AD in Daily Life
44. I am embarrassed by the way my child's skin looks. Emotion .797 .157 .014 .122 .058 .839
25. I am bothered by the reaction of strangers to this skin condition. Emotion .677 .104 .151 .042 .099
33. I worry that this skin condition will affect my child's ability to make friends. Emotion .639 .206 .005 .132 .048
38. I worry that this skin condition will affect my child's self-esteem. Emotion .601 .223 .016 .008 .055
39. My child's skin condition makes me feel sad or depressed. Emotion .498 .190 .133 .100 .042
16. I/we avoid taking photos of my child because of this skin condition. Emotion .443 .002 .236 .064 .087
32. I worry about the side effects from treatments for this skin condition. Emotion .021 .796 .044 .066 .010 .818
13. I worry that my child's skin condition will continue. Emotion .027 .655 .121 .196 .089
31. My child sleeps in my bed because of this skin condition. Sleep .016 .518 .182 .037 .002
35. This skin condition has affected how conﬁdent I feel about my child's
medical care.
Emotion .006 .511 .121 .030 .102
3. My child's skin condition affects how well my spouse and I sleep. Sleep .373 .477 .352 .150 .045
26. I am disappointed that my child has this skin condition. Emotion .253 .443 .286 .298 .014
28. I worry that my child is exposed to things that may worsen this skin
condition.
Emotion .300 .419 .148 .198 .116
42. I blame myself or feel guilty that my child has this skin condition. Emotion .314 .389 .178 .048 .165
4. I am bothered that this skin condition affects our vacation plans. Family and Social Function .045 .089 .814 .083 .018 .792
7. I am bothered that my family stays home more because of this skin condition. Family and Social Function .080 .144 .696 .176 .007
8. I am bothered that this skin condition affects our relationships with relatives. Family and Social Function .260 .069 .581 .064 .015
5. This skin condition affects our social life. Family and Social Function .105 .012 .537 .146 .028
11. I worry about leaving my child with others (babysitters, relatives) because of
this skin condition.
Family and Social Function .185 .172 .478 .029 .031
18. I am bothered by how much time is needed to care for my child's skin
condition.
Emotion .184 .083 .032 .783 .069 .826
37. I am angry that my child has this skin condition. Emotion .128 .051 .081 .621 .040
15. I am frustrated with my child's skin condition. Emotion .090 .166 .064 .575 .069
45. My child's skin condition makes it hard to do what I enjoy. Family and Social Function .178 .130 .236 .551 .006
20. My child's skin condition affects my spouse's or my work performance due
to missed time and decreased productivity.
Family and Social Function .022 .051 .118 .471 .047
30. My child's skin condition has strained my relationship with my spouse or
partner.
Family and Social Function .370 .133 .031 .420 .001
48. I feel that I have adapted to the everyday life of caring for a child with atopic
dermatitis.
y .066 .008 .036 .059 .739 .734
50. I can deal with the prospect of long-term care for my child. y .074 .207 .075 .040 .718
49. I feel that our whole family is helping with the care of my child's atopic
dermatitis.
y .011 .066 .004 .036 .576
51. I can accept that I cannot manage the situation perfectly. y .170 .168 .003 .037 .503
47. This skin condition has made me more careful about my child's
environment.
y .017 .220 .057 .022 .488
46. This skin condition has made me more careful about my child's diet. y .143 .110 .141 .100 .399
Principal axis factoring.
Promax with Kaiser Normalization.
Rotation converged in 7 iterations.
y Additional items in Japanese version.
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(P < 0.01 in all instances).
Validity
Concurrent validity
A correlation was measured using the Japanese version of DFI
scale and the JCMV-CADIS with the following correlations shown:
“Symptoms” (.563), “Activity Limitations and Behavior” (.499),
“Emotions Related to Social Factors” (.448), “Emotions Related to
the Child's Condition” (.546), “Family and Social Function” (.519),
and “Complexity of Care” (.616) (P < 0.01 for each). “Approaches to
Management of AD in Daily Life” was not shown to be correlated
with the DFI.
Total SCORAD score when correlated with the JCMV-CADIS
revealed correlations with “Symptoms” (.430), “Activity Limita-
tions and Behavior” (.232), “Emotions Related to Social Factors”
(.210), and “Emotions Related to the Child's Condition” (.239)
(P < 0.01 for each). Total SCORAD score did not correlate with
“Complexity of Care” or “Approaches toManagement of AD in Daily
Life.” Only “Symptoms” showed a moderate correlation with Total
SCORAD, with the rest showing low correlation. Details are shown
in Table 4.
Discriminant validity
PS-SF total score when correlated with the JCMV-CADIS
revealed correlations with “Symptoms” (.258), “Activity Limita-
tions and Behavior” (.410), “Emotions Related to Social Factors”
(.362), “Emotions Related to the Child's Condition” (.258), “Family
and Social Function” (.272), and “Complexity of Care” (.368). “Ap-
proaches to Management of AD in Daily Life” correlated signiﬁ-
cantly with the FAI subdomain and “Family Communication” (.216),
“Family Evaluation” (.210), and “Family Cohesion” (.196) (P < 0.01
for each). Details are shown in Table 4.
Discussion
About concurrent validity of the JCMV-CADIS, it was shownwith
all factors except “Approaches to Management of AD in Daily Life.”
“Approaches to Management of AD in Daily Life” consists solely of
items speciﬁc to the new Japanese version of the CADIS, so one can
reasonably assume that this represents concepts not measured on
the existing scale. While there is as yet no scale available to mea-
sure the concurrent validity of this factor, a previous study found
that characteristics of AD and parenting stress are related to “dif-
ﬁculties of daily care”.25,26 The “Approaches to Management of AD
in Daily Life” factor captures this concept and is certainly an
important family-related factor ﬁtting with the general theme of
the JCMV-CADIS.
About discriminant validity, “Approaches to Management of AD
in Daily Life”was not found to correlate signiﬁcantly with the PS-SF,
but it was found to correlate with three subdomains of FAI. The
added items in “Approaches to Management of AD in Daily Life”
measure qualities not found in the original scale, and their general
concept is similar to the FAI; namely, a measure of family function.
Factor analysis of the JCMV-CADIS revealed a larger number of
factors than in the original version. However, this tool is not
intended to be applied as a simple clinical screening instrument,
but rather as an instrument for detailed measurement for specialty
clinics or clinical trials. As a result, a larger number of factors are
appropriate.
As in the original version of the scale, the Child domain in the
JCMV-CADIS consists of two factors. A few items were changed, but
the Child domain shares the same general factor structure as the
original.
C. Yamaguchi et al. / Allergology International 65 (2016) 312e319318“Emotion” was a single factor in the original version, but had to
be divided into two factors in the JCMV-CADIS. The ﬁrst such factor,
“Emotions Related to Social Factors,” is strongly inﬂuenced by
Japanese culture. Benedict pointed out that American culture is
primarily a “culture of guilt,” while Japanese culture is more a
“culture of shame,” in which individuals place a great deal of
importance on how they are seen by others, rather than on how
they see themselves.27 Japanese parents are thus very sensitive to
the appearance of their children and how others might react to it,
and the items related to outward appearance exhibit this particular
aspect of Japanese culture very strongly. The second factor, “Emo-
tions Related to the Child's Condition,” is quite similar to the more
traditional concept of the “Emotion” on the original version.
“Complexity of Care” does not appear in the original version of
the scale. Since 97.4% of respondents in this study were mothers of
children with AD, this factor represents the fact that the primary
burden of care for children with AD in Japan falls on the shoulders
of their mothers. Regarding the Global Gender Gap Report28 and
the Organisation for Economic Co-operation and Development
report29 on “Balancing paid work, unpaid work and leisure,” Japa-
nese men tend to immerse themselves in work rather than do-
mestic duties, so Japanese women carry the brunt of household
work. In Japanese families, where household work is seen as pri-
marily the job of the mother, one can assume that mothers bear the
primary burden for both housework and the care of children with
AD. One can easily imagine that the complexity of care is felt most
keenly by mothers carrying this dual responsibility.
“Approaches to Management of AD in Daily Life” concerns
managing family expectations, outlooks, and preventive measures.
“Daily Life” concerns issues faced by any family, such as diet and
environment, but daily life for childrenwith AD involves continuous,
long-term attention to many speciﬁc issues in order to ensure that
symptoms are not exacerbated. Japan differs fromWestern countries
in a number of ways in this regard. Examples include differences in
diet, the use of futons rather than beds, and the practice of removing
shoes when entering the home. In addition, Triandis stated that Ja-
pan's collectivist culture often leads to stronger parent-child bonds,
but weaker spouseespouse bonds, than in individualistic nations.30
Japanese mothers might thus be willing to make more sacriﬁces for
the sake of their children. Contrasting with this perspective, the
factor “Approaches to Management of AD in Daily Life” includes a
number of items related to caring for the whole family with an eye
toward the long-term and accepting care that accommodates the
family as a whole, rather than care that is “perfect.” This factor's
focus on the functioning of the family as a whole can help families
move forward with actions that reduce the burden of care and
overcome difﬁculties in daily life by keeping communication open
and strengthening family bonds. For all of these reasons, this new
factor is needed to address the particular characteristics of the Jap-
anese family structure and the roles within it.
Limitations of this study
Retest surveys were completed after 48 h. This represented only
a short period between testing and retesting and may have led to
recall bias. However, use of this interval was deemed appropriate,
since AD in children generally responds well to treatment within
only a few days.
The clinical applicability is yet to be tested, and further evalu-
ation of clinical applicability is needed.
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